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Background: Regular intake of medicines prevents hospitalization and improves   treatment out-
comes in patients with chronic diseases; however, requires good patient–physician   communication. 
Yet, this communication is often insufficient and characterized by   misunderstandings. This paper 
aimed to explore whether a training session on medication counseling for general practitioners 
(GPs) can improve patient satisfaction about information on medicines.
Methods: Within a seamless care project (HeiCare®), a questionnaire to assess patient satisfaction 
with information on medicines and other questions related to medication issues was distributed 
among 370 patients. Results were returned to physicians in a feedback report, discussed in a 
training session, and a subsequent second questionnaire was sent to patients.
Results: Patients showed a significant increase in satisfaction with overall information on medicines 
and with information on potential problems when experiencing medication counseling after their 
GP received a feedback report and/or training session.
Conclusion: Individual feedback and training sessions can improve medication counseling and 
GPs’ awareness of patients’ attitudes toward medicines and thus increase patients’ satisfaction 
with medicines information received. Regular feedback to the GP on patients’ satisfaction with 
information and patients’ beliefs in medicines can be obtained by patient surveys or by addressing 
these issues in regular medication counseling encounters. Physicians need to be trained to listen 
to patients’ views and concerns on medication.
Keywords: medication counseling, patient satisfaction, beliefs in medicines, feedback, general 
practice
Introduction
It is well known that information on medication and regular medication intake plays an 
important role in the successful treatment of diseases.1 This is acknowledged by all health 
care professionals and, therefore, a lot of effort has been put into supplying patients with 
information such as package inserts that follow recommendations for comprehensible 
medication information.2,3 In addition to written information, it is especially important 
to counsel patients with respect to the importance of following the prescribed regi-
men and on how to take the medication appropriately.4 The correct and reliable intake 
of medicines depends on the kind of information provided to the patients and on the 
information given to patients on the impact of medication regarding illness.5–7
General practice plays a pivotal role for medication prescribing and counseling, 
eg, in 2009 in Germany 52% of medicines were prescribed by general practitioners 
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(GPs) and 17% by internists involved in primary care.8 
Especially patients on long-term medication need regular 
medication counseling at various stages: when renewing 
their prescription, when receiving additional medicines, for 
example, from specialists or for an acute episode, or when 
being discharged from hospital. Medication counseling at 
these stages can help identify adverse effects, interactions 
of medicines, and wrong application. In addition, patients’ 
beliefs about medicines play an important role and can 
change over time due to formal and informal information 
patients receive via media, friends and relatives, and other 
health care professionals.9 These aspects as well as patient 
satisfaction with information on medicines have proven to 
have impact on medication adherence.10,11
However, there is often a mismatch in medication-related 
communication between patients and physicians, and medica-
tion counseling is therefore often not successful due to differ-
ences between patient and physician perception regarding the 
prescribed medication regimens.12,13 In addition, physicians 
overestimate the time they spend communicating about 
medications to patients,14 and that time is mostly spent with 
information on action and usage of medicines.15 Only a small 
proportion of time is spent on exploring patients’ beliefs or 
concerns about medicines as well as other clinically relevant 
aspects such as possible interactions or nonadherence.16,17 
Physicians are often not aware of patients who consider pre-
cisely these aspects as important.3 On the other side, patients 
often remain passive and seldom mention fears and concerns 
regarding medicines towards physicians.4 Communicating 
medication-related information that meets patients’ needs 
is necessary so that patients are satisfied and subsequently 
take their medicines correctly and reliably.18
To raise awareness of patient needs regarding medication 
information and in order to change professional communica-
tion of GPs on medicine-related issues, training sessions for 
GPs on medication counseling are thus necessary.
Feedback has proven to be an effective method to change 
professional behavior and clinical performance among 
health professionals,19 especially when being compared with 
peers.20 In order to be effective, patient feedback provided 
to   physicians needs to be based upon structured data and 
goals.21 Although physicians seem to be skeptical towards 
patient feedback,22 it can improve the physician–patient 
interaction.23 A systematic review indicated a positive impact 
on clinical performance when education was coupled with 
feedback being even more likely to be effective when pro-
vided by an authoritative source over an extended period 
of time.24
Within a project designed to improve medication com-
munication across healthcare sectors (HeiCare®), the aim was 
to investigate whether a multifaceted intervention to improve 
medication counseling had an impact on patient   satisfaction 
with information on medicines. The HeiCare®   project was 
conducted by the University Hospital Heidelberg in coopera-
tion with a large compulsory health insurance fund.25 Fifty-six 
primary care practices participated in the project and enrolled 
1002 patients. Inclusion criteria for patients were: long-term 
medication for a chronic disease,   participation in a disease 
management program, and an expected hospitalization in 
the medium term. In general   practices, patients’   medication 
underwent a quality check, consisting of an internet-based 
knowledge database (AiDPraxis www.aidpraxis.de) checking 
for medication interactions and other drug-related problems, 
and a medication consultation with their GP. The internet-
based knowledge database was also used to transfer medica-
tion data to the University Hospital Heidelberg when patients 
were admitted to hospital.
A primary patient survey (T0) (March–December 2007) 
using the Satisfaction with Information about Medicines 
Scale-German version (SIMS-D)26 identified that patients 
were mostly satisfied with the information they received on 
“action and usage” of medication but less satisfied with the 
information on “potential medication related problems” in 
general practice.
The aim of this study was to examine whether patients’ 
satisfaction with information about medicines increases 
if their physicians receive feedback on their patients’ 
  satisfaction with information about medicines.
Methods
An intervention was conducted to investigate if a feed-
back report and a training session for GPs could improve 
medication counseling in general practice and hence patient 
satisfaction.
intervention
The results of the primary survey mentioned above were 
summed up in a feedback report. To ensure patient   anonymity 
it was only sent to GPs if at least ten of their patients had 
returned the questionnaire. This was the case with 19 of 
the participating GPs, who then received their feedback 
report in February 2008. The feedback report consisted of 
some introductory words regarding the survey procedure. 
In the following section patient results were displayed in 
comparison to the overall patient sample (benchmark): 
response rate, sociodemographic patient data, SIMS-D score, 
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scale and subscale scores, Medication Adherence Report 
Scale-German version (MARS-D),27 and results on ques-
tions regarding medication management. The comparison 
with other practices allowed the GPs to identify their own 
strengths and weaknesses. The report concluded with some 
remarks on how to handle the results emphasizing that the 
patient sample may not be representative for the practice. 
It encouraged the GP to take a team approach when taking 
action for improvement.
The 19 GPs were then invited to attend a 120-minute 
training session on medication counseling (April 2008). 
Twelve physicians attended one of the two training sessions 
offered. Reasons given by the physicians for not being able 
to attend were time restrictions and other   commitments. 
The sessions were conducted by CM and SJ and consisted 
of an indepth discussion of the patient assessment results. 
A reflection and exchange of personal strategies in medica-
tion counseling followed. Five bullet points for giving patients 
a guideline for effective medication counseling, which were 
based on literature and the findings of the survey, were given 
to the GPs:
•	 Ask patients if the medicines are being tolerated.
•	 Ask patients if they are taking further medicines (over-
the-counter, ie, nonprescription, drugs).
•	 Adapt information to individual patient needs.
•	 Ensure that patients understand directions.
•	 Ask about fears and concerns regarding medication.
GPs were then asked to set a personal goal for themselves 
in medication counseling in daily practice.
The training session was evaluated with a written survey 
consisting of nine questions on content, practical relevance 
of information, didactics, and organizational aspects on a 
scale ranging from “very good” (one) to “very bad” (six). 
The discussion was recorded in writing and audiotaped. 
Approval was obtained by the participating physicians as 
well as the Ethics Committee of the Medical Faculty of the 
University of Heidelberg.
Questionnaire
A second questionnaire (T1) was administered to the patients 
whose GP had attended the training session and/or received 
a feedback report at the end of July 2008. This date was 
chosen because in Germany patients with chronic diseases 
often visit their GP for a new prescription at the beginning 
of a quarter. It was assumed that by the end of the month 
most patients would have seen their GP.
T1 consisted of SIMS-D,11 MARS-D, three questions 
regarding medication management in the patient’s general 
practice, and self-reported number of medicines. The Beliefs 
about Medicines Questionnaire (BMQ)28 as well as one 
question asking if the patient had experienced medication 
counseling with his GP in the last 10 weeks were also added. 
Patient’s sociodemographic data (age, gender, education, 
self-reported diseases) had been collected with T0.
On enrolment, patients had agreed on participating in a 
voluntary patient survey, which had been approved by the 
Ethics Committee of the Medical Faculty of the University 
of Heidelberg.
Measures
SiMS-D
SIMS-D, developed by Rob Horne in England,10 comprises 
17 items which were derived from the recommendations of 
the Association of the British Pharmaceutical Industry. These 
give information on the type of information that patients need 
for a safe and accurate self-management of medication. It is 
a method of eliciting patients’ views on medication informa-
tion rather than defining the absolute quantity or quality of 
the information obtained. Patients are asked to rate each of 
the 17 aspects of the information they have received on their 
medication on a five-point scale: “too much,” “about right,” 
“too little,” “none received,” and “none needed.” Overall 
satisfaction with information received can be calculated by 
summing all items; higher scores indicating a higher degree 
of total satisfaction. Summing items one to nine (subscale 
one) identifies satisfaction with information about “action 
and usage of medication” (scores ranging from zero to nine); 
items ten to 17 (subscale two) identify satisfaction with 
information about “potential problems of medication” (scores 
ranging from zero to eight). SIMS-D therefore identifies 
unmet medicines information needs from the perspective of 
the individual patient. This is important because the patients’ 
views about their medicines influence adherence.10
BMQ
BMQ comprises 18 items and four scales. Two five-item 
scales assess patients’ beliefs about the necessity of their 
specific prescribed medication for controlling their illness 
and their concerns about potential negative consequences 
of taking it (“necessity” and “concern” scales). Two four-
item scales assess patients’ general beliefs about medicines 
regarding overuse and harm of medication (“general overuse” 
and “general harm” scales). Patients rate each question on 
a five-point scale ranging from “strongly disagree” (one) to 
“strongly agree” (five). Scores obtained for the individual 
items within each scale are summed to give a scale score 
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ranging from five to 25 for the necessity and concern scales, 
and from four to 20 for the general harm and general overuse 
scales.
Medication management
Medication management was assessed by asking if the patient 
had received a printed medication list from the physician 
(yes/no), if the physician usually inquired about further 
medication being taken, and if the physician asked whether 
the medication prescribed was being tolerated, using five 
response alternatives ranging from “always” to “never.”
Patient sample and data collection
The questionnaire was sent to the 370 patients who had 
returned T0 and whose physician had received a feedback 
report. As an incentive to fill in and send back the question-
naire, a monthly lottery drawing (two times 20 Euro) was 
conducted and a stamped envelope with the postal address 
of the University Hospital was enclosed. After 2 weeks a 
reminder was sent to those patients whose questionnaire had 
not been returned.
Statistical analysis
Data was entered and analyzed in IBM SPSS version 18.0 
(SPSS Inc, Chicago, IL). Patients were divided into two 
groups retrospectively: Group A, patients who indicated 
that they had received medication counseling within the last 
10 weeks (N = 168); Group B, patients who indicated that 
they had received no medication counseling within the last 
10 weeks (N = 63). Differences in sociodemographic data 
between Groups A and B were analyzed. Mean and standard 
deviation were calculated for the SIMS-D scores at T0 und 
T1 for both groups.
Data was analyzed using one-way repeated measures 
analysis of variance for Groups A and B to test whether the 
groups differed with regard to satisfaction with information 
about medicines (SIMS-D score) over time.
Scores for the BMQ (median and interquartile range) 
were calculated for Groups A and B at T1. To explore differ-
ences between groups, Mann–Whitney U test was applied.
Results
Physician sample
The 19 physicians who received a feedback report and/or 
took part in the training session had a mean age of 54.4 years 
(standard deviation [SD] 7.64 years) and 84.2% were male. 
They had taken up residence since an average of 19.8 years 
(SD 8.45 years). Seven of the practices (36.8%) were solo 
practices and over half of the practices (57.9%) were located 
in a rural area.
Evaluation of the training session  
and feedback reports
The training session was evaluated by all twelve participating 
physicians on a scale of “very good” (one) to “very bad” (six). 
Marks received were between 1.2 and 2.3, with a high aver-
age mark of 1.6. The following comments on the feedback 
report were given during the session:
•	 “I have become more aware of handing my patients a 
written medication plan. I thought I had always done so, 
but now I pay more attention to it.” (GP1, Session 1)
•	 “… I realized that you have to enquire more, such as 
which medicines the patient buys himself. I was sensitized 
and rethink things now. For example, I now pay more 
attention to side effects. I had no idea in the beginning, 
but the feedback report was good. I ask (the patient) more 
now.” (GP2, Session 2)
•	 “I also think the feedback reports are very good.” (GP5, 
Session 2)
•	 “Since then I always ask the patients which medicines 
they buy additionally.” (GP1, Session 2).
Patient questionnaire
Overall, 273 (73.4%) patients sent back the questionnaire. 
In 41 questionnaires the SIMS-D showed missing values, 
leaving 232 (62.7%) pairs at T0 and T1 to analyze (Figure 1). 
One hundred and sixty-eight (72.4%) patients indicated that 
they had experienced medication counseling within the past 
10 weeks with their GP.
Sample
Demographic data at T0 revealed that the overall sample 
was 68.7 years old and 56.3% were male. No significant 
differences in sociodemographic characteristics between 
Groups A and B were found, however a significant increase 
was identified for Group A in the number of medicines taken 
between T0 and T1 (Wilcoxon test P , 0.01) (Table 1).
Satisfaction with information about medicines
For patients who had received medication counseling in the past 
10 weeks, all SIMS-D scores increased between T0 and T1. 
For the 63 patients in Group B who had received no medication 
counseling in the past 10 weeks, satisfaction with information 
about medicines decreased in all scores (Table 2).
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N = 370
41 SIMS-D
incomplete
1 patient did not
indicate if he had
counseling or not
Group B: patients with no medication
counseling in the past 10 weeks
(since the training session)
SIMS-D–T0 and T1
N = 63 (27.2%)
Group A: patients with medication
counseling in the past 10 weeks
(since the training session)
SIMS-D–T0 and T1
N = 168 (72.4%)
97 dropouts
of which:
11 decreased, 4 moved, 8 poor
health, 74 unknown reasons
N = 273
(73.4%)
SIMS-D T0 and T1
N = 232 (62.7%)
Figure 1 Flow chart of the administration process of the study.
Abbreviations: SiMS-D, Satisfaction with information about Medicines Survey-German version; T0, primary patient survey; T1, second questionnaire administered to 
patients whose general practitioner had attended the training session and/or received a feedback report.
Table 1 Sociodemographic data, number of diseases, and number of medicines in the overall sample and both subgroups
Overall sample 
(N = 232)
Group A: medication counseling  
had taken place (N = 168)
Group B: medication   
counseling had not  
taken place (N = 63)
Age (T0) (n = 231/168/62) 
Mean age in years (range)
68.7 
(19–95)
68.7 
(19–95)
66.7 
(44–85)
Gender male (%) (n = 231/168/62) 56.3 55.4 58.1
Mother tongue German (%) (n = 221/160/61) 94.1 93.8 95.1
number of diseases (T0) Mean (range)  
(n = 232/168/63) (self report)
3.5 
(1–8)
3.5 
(1–8)
3.4 
(1–7)
number of medicines T0 (%) (n = 228/165/62) (self report)
  1–3 
  4–7 
  8–10 
  .10
22.4 
50.0 
17.5 
10.1
23.6 
46.7 
18.2 
11.5
19.4 
58.1 
16.1 
6.5
number of medicines T1 (%) (n = 232/168/63) (self report)
  1–3 
  4–7 
  8–10 
  .10
16.8 
52.2 
19.4 
11.6
17.3 
49.4 
19.0 
14.3
15.9 
58.7 
20.6 
4.8
Wilcoxon test for number of medicines in each  
group between T0 and T1
P , 0.01 P = 0.491
Abbreviations: T0, primary patient survey; T1, second questionnaire administered to patients whose general practitioner had attended the training session and/or received 
a feedback report.
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One-way repeated measures analysis of variance revealed 
no difference over time within the whole group. A difference 
was found over time between the groups regarding SIMS-D 
overall satisfaction (F[1, 229] = 5.07, P = 0.025) and the 
subscale potential problems of medication (F[1,  229] = 5.86, 
P = 0.017). No difference between the groups over time was 
revealed for the subscale action and usage of medication 
(F[1, 229] = 1.83, P = 0.178) (Table 3).
Beliefs in medicines
BMQ showed no significant differences between the two 
groups for specific necessities and specific concerns about 
medicines however a difference was detected in general 
overuse and general harm scales showing that patients who 
didn’t receive medication counseling (Group B) had higher 
scores in these two scales (Table 4).
Discussion
Patients showed a significant increase in satisfaction with over-
all information on medicines and with information on potential 
problems when experiencing medication counseling after their 
GP received a feedback report and/or training   session.   Looking 
at the whole sample over time, no significant difference in satis-
faction could be found; however, patients’ satisfaction differed 
significantly between the two groups with and without medica-
tion counseling after their GPs attended the training session. 
This can be assumed to be a result of the intervention directing 
physicians’ attention to medication counseling considering that 
usually information on action and usage is communicated by 
physicians.29,30 Satisfaction with information on medication-
related problems increased especially for those patients who 
received medication counseling, suggesting that physicians 
may have paid more attention to address these issues when 
talking about medicines. The comments of the physicians on 
the feedback report support these findings.
Patients who didn’t receive medication counseling 
(Group B) seemed to be more skeptical and concerned about 
general harm and overuse of medicines than patients in 
Group A. This may be due to different individual concepts 
of illness,31,32 and could be a reason why they did not have 
medication counseling in the 10 weeks prior to T1 despite the 
fact that multimorbid patients in Germany visit a physician, on 
average, twelve times a year.33 Especially for these patients, 
regular and planned medication reviews with a health profes-
sional may help increase patient satisfaction by addressing 
patients’ individual information needs as well as their beliefs 
and concerns regarding medicines.
The results support findings that feedback combined 
with a training session can support change in professional 
  behavior.19,34 However, one feedback report and one training 
session are most likely not sufficient to sustain long-term 
change. Ongoing training and reflection of professional 
behavior is therefore required.
There are limitations to the study that merit discussion. 
Firstly, a causal relationship between feedback report/ 
training session and increase in patient satisfaction cannot 
be drawn because many factors such as beliefs in medi-
cines,31 individual concepts,32 or perceived health status35 can 
Table 3 One-way repeated measures analysis of variance
Factor Factor *group
SiMS-D: overall satisfaction F(1, 229) = 0.062 P = 0.803 F(1, 229) = 5.07 P = 0.025*
SiMS-D: action and usage F(1, 229) = 0.412 P = 0.521 F(1, 229) = 1.83 P = 0.178
SiMS-D: potential problems F(1, 229) = 0.905 P = 0.342 F(1, 229) = 5.86 P = 0.017*
Note: *Shows statistical significance (P , 0.05).
Abbreviations: SiMS-D, Satisfaction with information about Medicines Survey-German version.
Table 2 Satisfaction with information about Medicines Survey scores at T0 and T1
Group A: medication counseling had  
taken place  
(N = 168)
Group B: medication counseling  
had not taken place  
(N = 63)
T0 T1 T0 T1
Mean SD Mean SD Mean SD Mean SD
SiMS-D: overall satisfaction 12.1 4.35 12.7 4.23 10.0 5.42 9.1 5.44
SiMS-D: action and usage 7.2 2.16 7.6 2.13 6.3 2.81 6.2 2.80
SiMS-D: potential problems  
of medication
4.9 2.71 5.2 2.79 3.7 3.21 3.0 2.01
Abbreviations: SD, standard deviation; SiMS-D, Satisfaction with information about Medicines Survey-German version; T0, primary patient survey; T1, second questionnaire 
administered to patients whose general practitioner had attended the training session and/or received a feedback report.
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also   influence patients’ satisfaction with information on 
  medicines. In addition, the sample represents only motivated 
GPs who were willing to participate in the HeiCare® proj-
ect, attend the training sessions, and reflect on professional 
behavior, maybe leading to biased results. Patients were asked 
whether they received medication counseling; however, it is 
not known what the counseling situation consisted of and in 
which   situation the physician–patient communication about 
medication occurred.
These results cannot be generalized as no random 
a  ssignment to the groups was performed and no   comparison 
of patients with nontrained GPs was possible in this study.
Conclusion
Individual feedback and training sessions seem to help 
improve medication counseling and GPs’ awareness of 
patients’ attitudes toward medicines, thus increasing 
patients’ satisfaction with medicines information received. 
Training on medication counseling is an ongoing process 
and physicians need to be accompanied over a longer period 
of time to change professional behavior in medication 
counseling from an incidental event at the end of a consulta-
tion to a proactive and regular patient-centered encounter. 
  Individualized information concerning potential drug-related 
problems and medicine taking should be addressed in regular 
medication reviews helping to ensure medication safety.
Patients need to be given an opportunity to express their 
own beliefs and concerns about medication, which will also 
increase patient satisfaction. Results from patient surveys can 
be used in feedback reports and training sessions to help physi-
cians reflect on their professional behavior and to encourage 
them to focus on patient-centered medication issues. This will 
lead to higher patient satisfaction and can help patients adhere 
to medication regimens supporting their treatment.
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